Misleading ads case: SC slams Baba Ramdev, Patanjali

Published On 2024-04-03 11:52 GMT   |   Update On 2024-04-03 11:52 GMT
Advertisement

Coming down heavily on the misleading ads matter, the Supreme Court refused to accept the apology tendered by Patanjali's Managing Director (MD) by terming it as "perfunctory". Further, while considering the contempt plea filed by the Indian Medical Association (IMA), the Apex Court described the acts of Baba Ramdev after giving the undertaking, to be in absolute defiance of the Supreme Court's order.

Advertisement

Slamming the yoga guru Ramdev and Patanjali MD Balkrishna for their "absolute defiance" in not filing proper affidavits of compliance in the misleading advertisement case and breaking "every barrier", the Apex Court also disapproved of the Patanjali MD’s statement that the Drugs and Cosmetics (Magic Remedies) Act is "archaic".

For more information, click on the link below:



Full View
Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News